Alexander Klibanov

Alexander Klibanov is the Novartis Professor of Chemistry and Bioengineering at the Massachusetts Institute of Technology. Alexander's research interests include enzyme chemistry and biotechnology, protein drug delivery and formulation, stability and stabilization of pharmaceutical proteins and biochemistry in extreme environments.

Alexander is a Member of the National Academy of Science and is known for greatly advancing the field of non-aqueous enzymology, the development methods for allowing enzymes to function in media such as organic solvents, rather than water. Alexander has authored over 270 scientific papers and has 16 issued U.S. patents. Alexander has given over 350 invited presentations and is a member of eight journal editorial boards.

Alexander has received numerous prestigious professional awards including the Leo Friend Award, the Ipatieff Prize, the Marvin J. Johnson Award and the Arthur C. Cope Scholar Award, all from the American Chemical Society, as well as the International Enzyme Engineering Award. Dr. Klibanov is a member of both the U.S. National Academy of Sciences and the National Academy of Engineering.

In addition, Alexander has started several biotechnology companies and has been a Member of the Scientific Advisory Board at BIND Therapeutics and SiO2 Medical Products.

Alexander Klibanov is the Co-Founder at Pulmatrix, based in United States, North America. With a background in Biotechnology, Alexander Klibanov has a rich history of leadership and innovation.Alexander Klibanov studied M.S. Chemistry at Moscow State University. Explore their detailed professional journey, key connections, and contributions to the industry on our platform.